These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 31481274

  • 1. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q, Zhu J, Wu Y, Wen H, Xia L, Wu X, Ju X.
    Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 3. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan 23; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    Chen P, Jiao L, Ren F, Wang DB.
    BMC Cancer; 2020 May 14; 20(1):423. PubMed ID: 32410650
    [Abstract] [Full Text] [Related]

  • 10. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 May 14; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 11. The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.
    Wang Y, Cui T, Du L, Xu X, Tian B, Sun T, Han C, Zhao X, Jing J.
    J Clin Lab Anal; 2017 Jan 14; 31(1):. PubMed ID: 27435426
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.
    Chen W, Xiu S, Xie X, Guo H, Xu Y, Bai P, Xia X.
    Radiat Oncol; 2022 Jan 10; 17(1):6. PubMed ID: 35012582
    [Abstract] [Full Text] [Related]

  • 14. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L, Cheng J, Zhou M, Yao Z, Zhang Y.
    J Cancer Res Clin Oncol; 2012 Feb 10; 138(2):239-46. PubMed ID: 22102174
    [Abstract] [Full Text] [Related]

  • 15. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V, Lubrano A, Pérez-Regadera JF, Torné A, Gil-Moreno A, Tejerizo-Garcia Á, Vergés R, Díaz-Feijoo B, SEGO Spain-GOG Group.
    Gynecol Oncol; 2021 Aug 10; 162(2):407-412. PubMed ID: 34119366
    [Abstract] [Full Text] [Related]

  • 16. Serum expression level of squamous cell carcinoma antigen, highly sensitive C-reactive protein, and CA-125 as potential biomarkers for recurrence of cervical cancer.
    Guo S, Yang B, Liu H, Li Y, Li S, Ma L, Liu J, Guo W.
    J Cancer Res Ther; 2017 Aug 10; 13(4):689-692. PubMed ID: 28901315
    [Abstract] [Full Text] [Related]

  • 17. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M, Sakuragi N, Okamoto K, Todo Y, Minobe S, Nomura E, Negishi H, Oikawa M, Yamamoto R, Fujimoto S.
    Acta Obstet Gynecol Scand; 2002 May 10; 81(5):451-7. PubMed ID: 12027820
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis.
    Huang L, Zheng M, Liu JH, Xiong Y, Ding H, Tang L, Wang HY.
    Chin J Cancer; 2010 Apr 10; 29(4):431-5. PubMed ID: 20346221
    [Abstract] [Full Text] [Related]

  • 19. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
    Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F.
    Gynecol Oncol; 2016 Jul 10; 142(1):115-119. PubMed ID: 27117922
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
    Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.
    Gynecol Oncol; 2012 Jan 10; 124(1):92-7. PubMed ID: 22014631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.